Other Vaccines - Moldova

  • Moldova
  • In Moldova, the revenue in the Other Vaccines market is estimated to reach US$3.01m in 2024.
  • It is expected to experience an annual growth rate (CAGR 2024-2029) of 9.46%, leading to a market volume of US$4.73m by 2029.
  • When compared globally, United States is projected to generate the highest revenue of US$24,730.00m in 2024.
  • Moldova is seeing an increasing demand for other vaccines, driven by a growing awareness of the importance of preventive healthcare.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Vaccines market in Moldova has been showing some interesting trends in recent years.

Customer preferences:
Moldova is a country with a high demand for vaccines, and this trend is expected to continue in the coming years. The population is becoming more aware of the importance of vaccination, and this is driving demand for a wider range of vaccines. In particular, there is a growing demand for vaccines that provide protection against diseases that are prevalent in the country.

Trends in the market:
One of the main trends in the Other Vaccines market in Moldova is the increasing demand for vaccines that protect against diseases such as hepatitis B, meningitis, and pneumococcal disease. These diseases are prevalent in the country and are a major cause of morbidity and mortality. As a result, there is a growing demand for vaccines that provide protection against these diseases.Another trend in the market is the increasing popularity of combination vaccines. These vaccines provide protection against multiple diseases in a single shot, and are becoming increasingly popular in Moldova. Combination vaccines are particularly popular among parents, as they reduce the number of shots that children need to receive.

Local special circumstances:
Moldova is a small country with a population of just over 3 million people. The country is located in Eastern Europe and is bordered by Romania and Ukraine. Moldova is a low-income country, and the healthcare system is underfunded and understaffed. This has led to a situation where many people are unable to access the healthcare services they need.

Underlying macroeconomic factors:
The Moldovan economy has been growing in recent years, but the country remains one of the poorest in Europe. The healthcare system is underfunded, and many people are unable to access the healthcare services they need. The government has been taking steps to improve the healthcare system, but progress has been slow.In conclusion, the Other Vaccines market in Moldova is showing some interesting trends, driven by a growing demand for vaccines that provide protection against diseases that are prevalent in the country. The increasing popularity of combination vaccines is also driving growth in the market. However, the healthcare system in Moldova is underfunded and understaffed, which is limiting the ability of people to access the healthcare services they need.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)